Gossamer Bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | $0.51 | $0.51 | $0.51 |
| Q2 2024 | 7 | -$0.17 | -$0.10 | -$0.15 |
| Q3 2024 | 2 | -$0.15 | -$0.15 | -$0.15 |
| Q1 2025 | 3 | -$0.19 | -$0.19 | -$0.19 |
| Q2 2025 | 3 | -$0.19 | -$0.19 | -$0.19 |
| Q3 2025 | 6 | -$0.19 | -$0.19 | -$0.19 |
| Q4 2025 | 5 | -$0.16 | -$0.16 | -$0.16 |
| Q1 2026 | 4 | -$0.18 | -$0.18 | -$0.18 |
| Q2 2026 | 3 | -$0.18 | -$0.18 | -$0.18 |
| Q3 2026 | 2 | -$0.18 | -$0.18 | -$0.18 |
| Q4 2026 | 2 | -$0.18 | -$0.18 | -$0.18 |
Gossamer Bio, Inc. Earnings Date And Information
Gossamer Bio, Inc. last posted its earnings results on Monday, August 12th, 2024. The company reported $0.22 earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by $0.01. The company had revenue of 95.84 M for the quarter and had revenue of 0 for the year. Gossamer Bio, Inc. has generated $-1 earnings per share over the last year ($-1.18 diluted earnings per share) and currently has a price-to-earnings ratio of -2.46. Gossamer Bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based on prior year's report dates.
Gossamer Bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/12/2024 | Q2 2024 | $0.23 | $0.22 | -0.01 | $114.29 M | $95.84 M |
| 05/07/2024 | Q1 2024 | -$0.19 | -$0.19 | 0 | $0 | |
| 03/05/2024 | Q4 2023 | -$0.20 | -$0.21 | -0.01 | $6.78 M | |
| 11/09/2023 | Q3 2023 | -$0.20 | -$0.21 | -0.01 | $0 | |
| 08/08/2023 | Q2 2023 | -$0.49 | -$0.45 | 0.04 | $0 | |
| 05/09/2023 | Q1 2023 | -$0.55 | -$0.57 | -0.02 | $0 | |
| 03/17/2023 | Q4 2022 | -$0.62 | -$0.61 | 0.01 | $0 | |
| 11/03/2022 | Q3 2022 | -$0.66 | -$0.69 | -0.03 | $0 | |
| 08/09/2022 | Q2 2022 | -$0.67 | -$0.77 | -0.1 | $0 | |
| 05/10/2022 | Q1 2022 | -$0.77 | -$0.81 | -0.04 | $0 | |
| 03/03/2022 | Q4 2021 | -$0.74 | -$0.74 | 0 | $0 | |
| 11/08/2021 | Q3 2021 | -$0.78 | -$0.80 | -0.02 | $0 | |
| 08/09/2021 | Q2 2021 | -$0.77 | -$0.80 | -0.03 | $0 | |
| 05/06/2021 | Q1 2021 | -$0.80 | -$0.78 | 0.02 | $0 | |
| 02/26/2021 | Q4 2020 | -$0.88 | $0 | |||
| 11/10/2020 | Q3 2020 | -$0.86 | -$0.80 | 0.06 | $0 | |
| 08/11/2020 | Q2 2020 | -$0.84 | -$1.00 | -0.16 | $0 | |
| 05/12/2020 | Q1 2020 | -$0.80 | -$0.87 | -0.07 | $0 | |
| 03/24/2020 | Q4 2019 | -$0.89 | $0 | |||
| 11/12/2019 | Q3 2019 | -$0.71 | -$0.80 | -0.09 | $0 |
Gossamer Bio, Inc. Earnings: Frequently Asked Questions
-
When is Gossamer Bio, Inc.'s earnings date?
Gossamer Bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, November 6th, 2024 based off last year's report dates.
-
How can I listen to Gossamer Bio, Inc.'s earnings conference call?
The conference call for Gossamer Bio, Inc.'s latest earnings report can be listened to online.
-
How can I read Gossamer Bio, Inc.'s conference call transcript?
The conference call transcript for Gossamer Bio, Inc.'s latest earnings report can be read online.
-
How much profit does Gossamer Bio, Inc. generate each year?
Gossamer Bio, Inc. (:GOSS) has a recorded net income of $0. Gossamer Bio, Inc. has generated $-1.18 earnings per share over the last four quarters.
-
What is Gossamer Bio, Inc.'s price-to-earnings ratio?
Gossamer Bio, Inc. (:GOSS) has a price-to-earnings ratio of -2.46 and price/earnings-to-growth ratio is -0.04.
